Документ применяется с 1 января 2024 года.

Список литературы

1. Шаталов К.В., Арнаутова И.В. Обструкция выхода из левого желудочка/Детская кардиохирургия. Руководство для врачей. Под редакцией Л.А. Бокерия, К.В. Шаталова. - М.: НЦССХ им. А.Н. Бакулева; 2016. - С. 444 - 482.

2. Roberts, W.C. Valvular, subvalvular and supravalvular aortic stenosis: morphologic features/Roberts W.C.//Cardiovasc. Clin. Ser. - 1973; 5: 97.

3. Beppu, S. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves/Beppu S., Suzuki S., Matsuda H., Ohmori F., Nagata S., Miyatake K.//Am. J. Cardiol. - 1993; 71: 322 - 327.

4. Bonow R.O., Carabello B.A., Chatterjee K. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists, endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 2006; 48: e1 - e148.

5. Зиньковский, М.Ф Врожденные пороки сердца/М.Ф. Зиньковский под редакцией А.Ф. Возианова. - Киев. 2010. - С. 738 - 790.

6. Myung, K. Park Aortic stenosis/Myung K. Park, MD//Pediatric Cardiology for Practitiones. - 2008. - P. 248 - 257.

7. Бондаренко, И.Э. Хирургическое лечение врожденного стеноза аорты: дисс. ... докт. мед. наук/И.Э. Бондаренко - М., 2003.

8. Brown JW., Stevens LS., Holly S. Surgical spectrum of aortic stenosis in children: a thirty-year experience with 257 children. Ann Thorac Surg., 1988, v. 45, p. 393 - 403.

9. Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия - 2015. Болезни и врожденные аномалии системы кровообращения. М.: НЦССХ им. А.Н. Бакулева; 2016. 208 с.

10. Braunwald, E. Congenital aortic stenosis. In: Clinical and hemodynamic findings in 100 patients/Braunwald E., Goldblatt A., Aygen M.M., Rockoff S.D., Morrow A.G.//Circulation. - 1963; 27: 426 - 462.

11. Gersony, W.M. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis or ventricular septal defect/Gersony W.M., Hayes C.J., Driscoll D.J. et al.//Circulation. - 1993; 87: 121 - 126.

12. Tawes, R.L. Congenital bicuspid aortic valve associated with coarctation of the aorta in children/Tawes R.L., Jr Berry C.L., Aberdeen E.//Br. Heart J. - 1969; 31: 127 - 128.

13. Glick, B.N. Congenitally bicuspid aortic valve in multiple family members/Glick B.N., Roberts W.C.//Am. J. Cardiol. - 1994; 73: 400 - 4.

14. Gale, A.N. Familial congenital bicuspid aortic valve: secondary calcific aortic stenosis and aortic aneurysm/Gale A.N., Mc Kusick V.A., Hutchins G.M., Gott V.L.//Chest. - 1977; 72: 668 - 70.

15. Godden, D.J. Stenosed bicuspid aortic valve in twins/Godden D.J., Sandhu P.S., Kerr F.//Eur. Heart J. - 1987; 8: 316 - 18.

16. McDonald, K. Familial aortic valve disease: evidence for a genetic influence?/McDonald K., Maurer B.J.//Eur. Heart J. - 1989; 10: 676 - 7.

17. Clementi, M. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance/Clementi M., Notari L., Borghi A., Tenconi R.//Am. J. Genet. - 1996; 62: 336 - 8.

18. Gotzsche, C.O. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome/Gotzsche C.O., Krag-Olsen B., Nielsen J., Sorensen K.E., Kristensen B.O.//Arch. Dis. Child. - 1994; 71: 433 - 6.

19. Van der Hauwaert, L.G. Cardiovascular malformations in Turner's and Noonan's syndrome/Van der Hauwaert, L.G., Fryns J.P., Dumoulin M., Logghe N.//Br. Heart J. - 1978; 40: 500 - 9.

20. Mazzanti, L. Heart disease in Turner's syndrome/Mazzanti L., Prandstraller D., Tassinari D. et al.//Helv. Pediatr. Acta. - 1988; 43: 25 - 31.

21. Rappo, P.D. Health supervision for children with Turner's syndrome/Rappo P.D.//American Academy of Pediatrics. Committee on Genetics. Pediatrics. - 1995; 96: 1166 - 73.

22. Douchin, S. Malformations and vascular complications associated with Turner's syndrome. Prospective study of 26 patients/Douchin S., Rossignol A.M., Klein S.K., Siche J.P., Baguet J.P., Bost M.//Arch. Mat. Coeur. Vaiss. - 2000; 93: 565 - 70.

23. Sybert, V.P. Cardiovascular malformations and complications in Turner syndrome/Sybert V.P.//Pediatrics. - 1998; 101: Eli.

24. John, R.M. Echocardiographic abnormalities in type IV mucopolysaccharidosis/John R.M., Hunter D., Swanton R.H.//Arch. Dis. Child. - 1990; 65: 746 - 9.

25. Tan, C.T. Valvular heart disease in four patients with Maroteaux-Lamy syndrome/Tan C.T., Schaff H.V., Miller F.A., Edwards W.D., Karnes P.S.//Circulation. - 1992; 85: 188 - 95.

26. Wippermann, C.F. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses/Wippermann C.F., Beck M., Schranz D. et al.//Eur. J. Pediatr. - 1995; 154: 98 - 101.

27. Fischer, T.A. Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (Ulrich-Scheie syndrome)/Fischer T.A., Lehr H.A., Nixdorf U., Meyer J.//Heart. - 1999; 81: 97 - 9.

28. Kettles, D.I. Left ventricular aneurysm, aortic valve disease and coronary narrowing in a patients with Hunter's syndrome/Kettles D.I., Sheppard M., Liebmann R.D., Davidson C.//Cardiovasc. Pathol. - 2002; 11: 94 - 6.

29. Baker, P.B. Cardiovascular abnormalities in progeria. Case report and review of the literature/Baker P.B., Baba N., Boesel C.P.//Arch. Pathol. Lab. Med. - 1981; 105: 384 - 6.

30. Carrel, T. Aortic gomograft and mitral valve repair in patient with Werner's syndrome/Carrel T., Pasic M., Tkebuchava T. et al.//Ann. Thorac. Surg. - 1994; 57: 1319 - 20.

31. Larson, E.W. Risk factors for aortic dissection: a necropsy study of 161 cases/Larson E.W., Edwards W.D.//Am. J. Cardiol. - 1984; 53: 849 - 55.

32. Roberts, C.S. Dissection of the aorta associated congenital malformation of the aortic valve/Roberts C.S., Roberts W.S.//J. Am. Coll. Cardiol. - 1991; 17: 712 - 16.

33. Gore, I. Dissecting aneurysm of the aorta. Pathologic aspects. An analysis of eithy-five fatal cases/Gore I., Seiwert V.J//Arch. Pathol. - 1952; 53: 121 - 41.

34. Douchin, S. Malformations and vascular complications associated with Turner's syndrome. Prospective study of 26 patients/Douchin S., Rossignol A.M., Klein S.K., Siche J.P., Baguet J.P., Bost M.//Arch. Mat. Coeur. Vaiss. - 2000; 93: 565 - 70.

35. Sybert, V.P. Cardiovascular malformations and complications in Turner syndrome/Sybert V.P.//Pediatrics. - 1998; 101: Eli.

36. Meunier, J.P. Acute type A aortic dissection in an adult patient with Turner's syndrome/Meunier J.P., Jazayeri S., David M.//Heart. - 2001; 86: 546.

37. Muscat, P. Vertebral artery dissection in Turner's syndrome: diagnosis by magnetic resonance imaging/Muscat P., Lidov M., Nahar T. et al.//J. Neuroimaging. - 2001; 11: 50 - 4.

38. Rosenfeld, R.G. Hypertension, aortic dilatation and aortic dissection in Turner's syndrome: a potentially lethal triad/Rosenfeld R.G.//Clin. Endocrinol. (Oxf). - 2001; 54: 155 - 6.

39. Hirose, H. Ruptured aortic dissecting aneurysm in Turner's syndrome: a case report and review of literature/Hirose H., Amano A., Takahashi A. et al.//Ann. Thorac. Cardiovasc. Surg. - 2000; 6: 275 - 80.

40. Peckman GB., Keith JD., Evans JR. Congenital aortic stenosis. Some observations on the natural history and clinical assessment. Can. Med. Assc. J., 1964, v. 91, p. 639 - 643.

41. Hossack KF., Neutze JM., Lowe JB., Barratt-Boyes BG. Congenital valvar aortic stenosis: natural history and assessment for operation. Br Heart J., 1980, v. 43, p. 561 - 573.

42. Zapfe H. Aortenstenose. Diagnostic. 1979, v. 12, N 111, p. 203 - 207.

43. Гетманский, В.Н. Современные подходы к хирургическому лечению врожденного стеноза аорты и полученные результаты/Гетманский, В.Н.//Дис. докт. мед. наук, Москва, 1984.

44. Aboulhosn J., Child JS. Left ventricular outflow obstruction: subaortic stenosis, bicuspid aortic valve, supravalvar aortic stenosis, and coarctation of the aorta. Circulation. 2006; 114: 2412 - 2422.

45. Baumgartner H., Hung J., Bermejo J., Chambers JB., Evangelista A., Griffin BP. et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. European Journal of Echocardiography. 2009; 10: 1 - 25.

46. Robinson JD, del Nido PJ, Geggel RL, Perez-Atayde AR, Lock JE, Powell AJ. Left ventricular diastolic heart failure in teenagers who underwent balloon aortic valvuloplasty in early infancy. Am J Cardiol. 2010; 106: 426 - 429.

47. Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, Tarasoutchi F, Grinberg M, Rochitte CE. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010; 56: 278 - 287.

48. Goldstein SA, Evangelista A, Abbara S, Arai A, Asch FM., Badano LP et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American society of echocardiography and the European association of cardiovascular imaging endorsed by the Society of cardiovascular computed tomography and Society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2015; 28: 119 - 82.

49. Schultz A.H., Localio A.R., Clark B.J., et al. Epidemiologic Features of the Presentation of Critical Congenital Heart Disease: Implications for Screening. Pediatrics 2008; 121; 751 - 757.

50. Das S, Chanani NK, Deshande S, Maher KO. B-Type Natriuretic Peptide in the Recognition of Critical Congenital Heart Disease in the Newborn Infant. Pediatr Emerg Care. 2012; 28(8): 735 - 8.

51. Saxena A, Sharma M, Kothari SS, Juneja R, Reddy SC, Sharma R, Bhan A, Venugopal P. Prostaglandin E1 in infants with congenital heart disease: Indian experience. Indian Pediatr 1998; 35: 1063 - 1069.

52. Liberman L, Gersony WM, Flynn PA, Lamberti JJ, Cooper RS, Stare TJ: Effectiveness of prostaglandin E 1 in relieving obstruction in coarctation of the aorta without opening the ductus arteriosus. Pediatr Cardiol 2004; 25: 49 - 52.

53. Cheng CF, Wu MH, Wang JK: Ductus-dependent aortic coarctation with a left-toright shunt through the ductus: report of one case. Int J Cardiol 1995; 49: 209 - 212; discussion 212 - 213.

54. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87: 67 - 9.

55. Viktor, 00000002.wmz The Long Therm Outcome of Open Valvotomy For Critical Aortic Stenosis in Neonates/Viktor 00000003.wmz, Nicodime Sinzobahamvya, Christopher Haun et al.//Ann. Thorac. Surg. - 2012; 94: 1519 - 26.

56. Detter, C. Aortic valvotomy for congenital valvular aortic stenosis: a 37-year experience/Detter C., Fischlein et al.//Ann. Thorac. Surg. - 2001; 71: 1564 - 71.

57. Arnold, R. Outcome After Mechanical Aortic Valve Replacement in Children and Young Adults/Arnold R., Ley-Zaporozhan J., Ley S. et al.//Ann. Thorac. Surg. - 2008; 85: 604 - 610.

58. Alsoufi, B. Mechanical valves versus the Ross procedure for aortic valve replacement in children: Propensity-adjusted comparison of long-term outcomes/Alsoufi, B., Al-Halees Z., Manlhiot C. et al.//Thorac. Cardiovasc. Surg. - 2009; 137: 362 - 370.

59. Kurosawa, H. Konno procedure (anterior aortic annular enlagerment) for mechanical aortic valve replacement/Kurosawa H.//Op. Tech. Thorac. Cardiovasc. Surg. - 2002; 7: 181 - 187.

60. Al Soufi, B. Superior results following the Ross/Al Soufi B., Al Halees Z., Manlhiot C. et al.//Eur. J. of Cardio-Thorac. Surg. - 2011; 39: 1067 - 69.

61. Weymann, A. Clinical experience with expanded use of the Ross procedure: a paradigm shift?/Weymann A., Dohmen P.M., Grubitzsch H. et al.//J. Heart Valve Dis. - May 2010; 19(3): 279 - 85.

62. Stulak, J.M. Spectrum and outcome of reoperations after the Ross procedure/Stulak J.M., Burkhart H.M., Sundt T.M. et al.//Circulation. - Sep. 21 2010; 122(12): 1153 - 8.

63. Sievers, H.H. Major adverse cardiac and cerebrovascular events after the Ross procedure: a report from the German-Dutch Ross Registry/Sievers H.H., Stierle U., Charitos E.L. et al.//Circulation. - Sep. 14 2010; 122(11 suppl.): 216 - 23.

64. David, T.E. Reoperations after the Ross procedure/David T.E.//Circulation. - Sep. 21 2010; 122(12): 1139 - 40.

65. Nicks R, Cartmill T, Bernstein L. Hypoplasia of the aortic root. The problem of aortic valve replacement. Thorax, 1970, v. 25, p. 339 - 346.

66. Konno S., Imai Y., Iida Y. et al: A new method for prosthetic valve replacement in congenital aortic stenosis associated with hypoplasia of the aortic valve ring, J Thorac Cardiovasc Surg., 1975, v. 70, p. 909 - 917.

67. Rastan H., Koncz J. Aortoventriculoplasty: a new technique for the treatment of left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg., 1976, v. 71, p. 920 - 927.

68. Manouguian S., Rastan H., Abu-Aishah N. et al. A new method for patch enlargement of hypoplastic aortic anulus. Proceedings International Congress of Cardiovascular Surgery, Athens, 1977, p. 94 - 99.

69. Egito, E.S., Transvaseular balloon dilatation for neonatal critical aortic stenosis: early and midterm results/Egito E.S., Moore P., O'Sullivan J. et al.//J. Am. Coll. Cardiol. - 1997; 29: 442 - 7.

70. Magee, A.G. Balloon dilatation of severe aortic stenosis in the neonate: comparison of anterograde and retrograde catheter approaches/Magee A.G. et al.//J. Am. Coll. Cardiol. - 1997; 30: 1061 - 6.

71. McCrindle, B.W. Are out comes of surgical versus transcatheter balloon valvotomy equivalent in neonatal critical aortic stenosis?/McCrindle B.W., Blackstone E.H., Williams W.G. et al.//Circulation. - 2001; 104: 1-152 - 1-158.

72. Robinson, B.Y. Balloon aortic valvotomy through a carotid cutdown in infants with severe aortic stenosis: results of the multi centric registry/Robinson B.Y. et al.//Cardiol. Young. - 2000; 10: 225 - 32.

73. Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В., Лобачева Г.В., Ведерникова Л.В. Под ред. Л.А. Бокерия. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых у новорожденных и детей. Методические рекомендации. М.: НЦССХ им. А.Н. Бакулева РАМН; 2014.

74. Рыбка М.М., Хинчагов Д.Я. Под ред. Л.А. Бокерия. Протоколы анестезиологического обеспечения кардиохирургических операций, выполняемых при ишемической болезни сердца, патологии клапанного аппарата, нарушениях ритма, гипертрофической кардиомиопатии, аневризмах восходящего отдела аорты у пациентов различных возрастных групп. Методические рекомендации. М.: НЦССХ им. А.Н. Бакулева РАМН; 2015.

75. Рыбка М.М., Хинчагов Д.Я., Мумладзе К.В., Никулкина Е.С. Под ред. Л.А. Бокерия. Протоколы анестезиологического обеспечения рентгенэндоваскулярных и диагностических процедур, выполняемых у кардиохирургических пациентов различных возрастных групп. Методические рекомендации. М.: НЦССХ им. А.Н. Бакулева РАМН; 2018.

76. Подзолков В.П., Кассирский Г.И. (ред.). Реабилитация больных после хирургического лечения врожденных пороков сердца. М.: НЦССХ им. А.Н. Бакулева; 2015.

77. Stout K., Daniels C., Aboulhosn J. et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 139 (14): e698 - e800.

78. Jochen Weil.//Guidelines for the Management of Congenital Heart Diseases in Childhood and Adolescence. Cardiology in the Young. 2017: 27 (Suppl. 3): S1 - S105.

79. Therese M. Giglia, M. Patricia Massicotte, James S. Tweddell, Robyn J. Barst, Mary Bauman, Christopher C. Erickson, Timothy F. Feltes, Elyse Foster, Kathleen Hinoki, Rebecca N. Ichord, Jacqueline Kreutzer, Brian W. McCrindle, Jane W. Newburger, Sarah Tabbutt, Jane L. Todd, Catherine L. Webb.//Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease: A Scientific Statement From the American Heart Association.//Circulation. 2013; 128: 2622 - 2703.

80. Habib G., Lancellotti P., Antunes M.J. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)

Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J Volume 36, Issue 44, 21 November 2015, Pages 3075 - 3128.

81. Goo H. W. et al. Computed tomography for the diagnosis of congenital heart disease in pediatric and adult patients//The international journal of cardiovascular imaging. - 2005. - Т. 21. - N. 2. - С. 347 - 365.

82. Mitchell B. J., Brown S. C. Management of severe aortic valve stenosis in the neonate: neonatal aortic valve stenosis//SA Heart. - 2014. - Т. 11. - N. 1. - С. 4 - 11.

83. Bautista-Hernandez V. et al. Current pharmacologic management of pediatric heart failure in congenital heart disease//Current vascular pharmacology. - 2011. - Т. 9. - N. 5. - С. 619 - 628.

84. Тагаева П.Н. Судьба больных, перенесших транслюминальную баллонную вальвулопластику аортального клапана в периоде новорожденности и в раннем детском возрасте: дис. на соиск. учен. степ. канд. мед. наук: код спец. 14.01.05/- Москва, 2010 г. - 105 с.: ил., табл.

85. Huhta J. C. et al. Echocardiography in the diagnosis and management of symptomatic aortic valve stenosis in infants//Circulation. - 1984. - Т. 70. - N. 3. - С. 438 - 444.

86. Клинические рекомендации по ведению детей с врожденными пороками сердца. Под ред. Л.А. Бокерия. М.: НЦССХ им. А.Н. Бакулева; 2014: 342 с.

87. Василевская, И.В. Отдаленные результаты операций протезирования митрального клапана в раннем детском возрасте/Василевская И.В.//Дис. канд. мед. наук, Москва, 2012.

88. Туманян М.Р., Абрамян М.А., Гуласарян Р.С., Котова А.Н., Трунина И.И. Протезирование клапанов сердца и антикоагулянтная терапия у детей первого года жизни. Детские болезни сердца и сосудов. 2011; (1): 29 - 31.

89. Бокерия Л.А., Ким А.И., Шаталов К.В., Абдувохидов Б.У., Василевская А.В., Рогова Т.В., Болтабаев И.И. Протезирование митрального клапана у детей раннего возраста. Детские болезни сердца и сосудов. 2011; (1): 4 - 8.

90. Salem, D.N. Antithrombotic Therapy in Valvular Heart Disease/D. N. Salem, D. H. Daudelin, H. J. Levine et al.//Chest - 2001. - Vol. 119. - P. 207 - 219.

91. Ahmed H, VanderPluym C Medical management of pediatric heart failure. Cardiovasc Diagn Ther 2021 Feb 1; 11. DOI: 10.21037/CDT-20-358

92. Masarone D, Valente F, Rubino M, Vastarella R, Gravino R, Rea A, et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol 2017 Aug 1; 58: 303 - 312.

93. Das BB, Moskowitz WB, Butler J Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials. Children 2021 Apr 22; 8: 322.

94. Shaddy R, George A, Jaecklin T, Lochlainn E, Thakur L, Agrawal R, et al. Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents. Pediatr Cardiol 2018 Mar 1; 39: 415 - 436.

95. Torok R, Li J, Kannankeril P, Atz A, Bishai R, Bolotin E, et al. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc 2018 Feb 1; 7. DOI: 10.1161/JAHA.117.007283

96. Kantor P, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol 2013 Dec; 29: 1535 - 1552.

97. Gong B, Li Z, Yat Wong PC Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth 2015 Dec 1; 29: 1415 - 1425.

98. Burkhardt BEU, 00000004.wmz G, Stiller B Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015 Mar 25; 2015.

99. Thorlacius E, Vistnes M, Ojala T, Keski-Nisula J, Molin M, Romlin B, et al. Levosimendan Versus Milrinone and Release of Myocardial Biomarkers After Pediatric Cardiac Surgery: Post Hoc Analysis of Clinical Trial Data. Pediatr Crit Care Med 2021; 22: E402 - E409.

100. Thorlacius EM, Suominen PK, 00000005.wmz H, Keski-Nisula J, Vistnes M, Ricksten SE, et al. The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial. Pediatr Crit Care Med 2019 Oct 1; 20: 947 - 956.

101. Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, et al. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study. Pediatr Crit Care Med 2012 Sep; 13: 542 - 548.

102. Raja SG, Rayen BS Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg 2006 Apr; 81: 1536 - 1546.

103. Hussey A, Weintraub R Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure. Paediatr Drugs 2016 Apr 1; 18: 89 - 99.

104. Thorlacius EM, 00000006.wmz H, Ojala T, 00000007.wmz K, Keski-Nisula J, Synnergren M, et al. Levosimendan Versus Milrinone for Inotropic Support in Pediatric Cardiac Surgery: Results From a Randomized Trial. J Cardiothorac Vasc Anesth 2020 Aug 1; 34: 2072 - 2080.

105. Long Y, Cui D, Kuang X, Hu S, Hu Y, Liu Z Effect of Levosimendan on Ventricular Systolic and Diastolic Functions in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol 2021 Jun 1; 77: 805 - 813.

106. Jothinath K, Balakrishnan S, Raju V, Menon S, Osborn J Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery. Ann Card Anaesth 2021 Apr 1; 24: 217 - 223.

107. Das B Current State of Pediatric Heart Failure. Children 2018 Jun 28; 5: 88.

108. Bajcetic M, Uzelac T, Jovanovic I Heart Failure Pharmacotherapy: Differences Between Adult and Paediatric Patients. Curr Med Chem 2014 Aug 13; 21: 3108 - 3120.

109. Colan S Review of the International Society for Heart and Lung Transplantation Practice guidelines for management of heart failure in children. Cardiol Young 2015 Sep 17; 25 Suppl 2: 154 - 159.

110. Del Castillo S, Shaddy R, Kantor P Update on pediatric heart failure. Curr Opin Pediatr 2019 Oct 1; 31: 598 - 603.

111. O'Connor M, Rosenthal D, Shaddy R Outpatient management of pediatric heart failure. Heart Fail Clin 2010 Oct; 6: 515 - 529.

112. 00000008.wmz M, Young R, Jhund PS, Solomon SD, Gong J, Lefkowitz MP, et al. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: Results fromPARADIGM-HF. Eur Heart J 2017 Apr 14; 38: 1132 - 1143.

113. Ahmed H, VanderPluym C Medical management of pediatric heart failure. Cardiovasc Diagn Ther 2021 Feb 1; 11. DOI: 10.21037/CDT-20-358.

114. Бердовская А.Н., Максимович Н.А. Практические аспекты профилактики инфекционного эндокардита у детей с врожденными пороками сердца. - Журнал ГГМУ Практикующему врачу. - 2005. - N 3. - с. 171 - 173.

115. Dajani A.S., Taubert K.A., Wilson W et al.: Prevention of bacterial endocarditis: Recommendations by the American Heart Association JAMA, 1997; 277: 1794 - 1801.

116. Durack D.T. Prevention of infective endocarditis. R. Engi J Med. 1995; 332: 38 - 44.

117. Patricia Smith, RN CPNP Primari Care in children with Congenital herat disease. Journal of Pediatric Nursing, Vol. 16, N 5 (october), 2001. - P. 308 - 319.

118. Рубаненко О.А. Инфекционный эндокардит. - Кардиология: новости, мнения, обучение. - 2016. - N 2(9). - с. 86 - 95.

119. Markus Khalil, Christian Jux, Lucie Rueblinger, Johanna Behrje, Anoosh Esmaeili, Dietmar Schranz. Acute therapy of newborns with critical congenital heart disease. - Translational Pediatrics. - Vol. 8, No 2. - P. 114 - 126.

120. Jeremy T. Affolter, Nancy S. Ghanayem. Preoperative management of the neonate with critical aortic valvar stenosis. - Cardiology in the Young (2014), 24, 1111 - 1116.